Latest releases

11.11.2020

FN, GR

Notice to convene Herantis Pharma Plc’s Extraordinary General Meeting of shareholders
11.11.2020

FN, GR

Herantis Pharma evaluates alternatives to finance its Research & Development pipeline and will convene an Extraordinary General Meeting
02.11.2020

Registration Details for Heratis Pharma’s R&D Update Webcast on 2 November 2020
01.11.2020

FN, GR

Herantis Pharma Announces R&D Update
30.10.2020

FN, GR

Ingrid Atteryd Heiman has decided to leave Herantis Pharma’s Board of Directors
30.10.2020

FN, IT

Herantis Pharma Oyj : Managers’ Transactions – Mats Heiman
26.10.2020

FN, GR

Herantis Appoints Tone Kvåle as Chief Financial Officer
15.09.2020

N, PR

Herantis Pharma publishes a July-September newsletter
11.09.2020

PR

Registration Information for Herantis Pharma’s Webinar on the Cerebral Dopamine Neurotrophic Factor (CDNF) Phase I-II Data Readout
04.09.2020

CR, PR

Herantis Pharma to Host a Webinar on the Cerebral Dopamine Neurotrophic Factor (CDNF) Phase I-II Data Readout

Quick links

Analyst Coverage »

Financial Calendar »

General Meetings »

Financial Information »

Share Information »

Share Monitor »

Investor Relations »

Corporate Governance »